公开(公告)号：US20240148741A1

公开(公告)日：2024-05-09

申请号：US18277445

申请日：2022-11-22

Applicant: Shionogi & Co., Ltd.

Inventor： Masato GOMI ,  Kensuke HORIUCHI ,  Masayuki MORIMOTO ,  Keisuke TAKAGAKI

IPC: A61K31/53 ,  A61K9/20 ,  A61K47/26 ,  A61P31/14

CPC classification number: A61K31/53 ,  A61K9/2054 ,  A61K47/26 ,  A61P31/14

Abstract: The present invention provides a formulation for oral administration, comprising a triazine derivative having virus proliferation inhibitory action.

公开(公告)号：US20240366622A1

公开(公告)日：2024-11-07

申请号：US18772892

申请日：2024-07-15

Applicant: Shionogi & Co., Ltd.

Inventor： Naomi HAYASHI ,  Masato GOMI ,  Shohei AIKAWA

IPC: A61K31/5383 ,  A61K9/20 ,  A61K9/28 ,  A61P31/16

Abstract: The present invention provides a preparation that is minimally colored through irradiation with light by coating a preparation containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, or a crystal thereof with a light stabilizing substance and a polymer, particularly with one or more of titanium oxide and talc used as the light stabilizing substance and hypromellose used as the polymer.

公开(公告)号：US20200375998A1

公开(公告)日：2020-12-03

申请号：US16764067

申请日：2018-11-15

Applicant: Shionogi & Co., Ltd.

Inventor： Naomi HAYASHI ,  Masato GOMI ,  Shohei AIKAWA

IPC: A61K31/5383 ,  A61P31/16 ,  A61K9/28 ,  A61K9/20

Abstract: The present invention provides a preparation that is minimally colored through irradiation with light by coating a preparation containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, or a crystal thereof with a light stabilizing substance and a polymer, particularly with one or more of titanium oxide and talc used as the light stabilizing substance and hypromellose used as the polymer.